Ali İnal

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

Kadir Eser, Arif Hakan Önder, Emel Sezer et al. · BMC Cancer · 2022 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Seda Kahraman, Enes Erul, Mustafa Seyyar et al. · Future Oncology · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

Doğan Uncu, Sercan Aksoy, Bülent Çetin et al. · Oncology · 2013 · 20 citations · Full text

Medicine, Oncology, Chemotherapy +15

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +12

PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Okan Avcı, Yakup İriağaç, Eyyüp Çavdar et al. · Journal of Geriatric Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Pharmacology +10